These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 14712427)
21. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats. Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775 [TBL] [Abstract][Full Text] [Related]
22. [Clinical Pharmacokinetics of Active Vitamin D3 and its derivatives, and Vitamin K2(Menatetrenone).]. Tsugawa N Clin Calcium; 2016; 26(11):1547-1558. PubMed ID: 27777388 [TBL] [Abstract][Full Text] [Related]
23. Dietary vitamin K2 supplement improves bone status after lung and heart transplantation. Forli L; Bollerslev J; Simonsen S; Isaksen GA; Kvamsdal KE; Godang K; Gadeholt G; Pripp AH; Bjortuft O Transplantation; 2010 Feb; 89(4):458-64. PubMed ID: 20177349 [TBL] [Abstract][Full Text] [Related]
24. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Hara K; Kobayashi M; Akiyama Y Bone; 2002 Nov; 31(5):575-81. PubMed ID: 12477571 [TBL] [Abstract][Full Text] [Related]
25. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. Shiraki M; Shiraki Y; Aoki C; Miura M J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566 [TBL] [Abstract][Full Text] [Related]
26. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178 [TBL] [Abstract][Full Text] [Related]
27. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment. Pitt P; Li F; Todd P; Webber D; Pack S; Moniz C Thorax; 1998 May; 53(5):351-6. PubMed ID: 9708225 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of Vitamin K2 for Glucocorticoid-induced Osteoporosis in Patients with Systemic Autoimmune Diseases. Shikano K; Kaneko K; Kawazoe M; Kaburaki M; Hasunuma T; Kawai S Intern Med; 2016; 55(15):1997-2003. PubMed ID: 27477405 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of Menatetrenone-4 postmenopausal Thai women. Bunyaratavej N; Penkitti P; Kittimanon N; Boonsangsom P; Bonjongsat A; Yunoi S J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S553-9. PubMed ID: 11853280 [TBL] [Abstract][Full Text] [Related]
30. Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. Sato Y; Kuno H; Kaji M; Saruwatari N; Oizumi K Am J Phys Med Rehabil; 1999; 78(5):457-63. PubMed ID: 10493456 [TBL] [Abstract][Full Text] [Related]
31. [Effect of combined treatment with vitamin K2 and 1 alpha-(OH)-vitamin D3 on bone loss in ovariectomized rats]. Hara K; Kobayashi M; Akiyama Y Nihon Yakurigaku Zasshi; 2001 Sep; 118(3):231-40. PubMed ID: 11577464 [TBL] [Abstract][Full Text] [Related]
32. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805 [TBL] [Abstract][Full Text] [Related]
33. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma]. Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343 [TBL] [Abstract][Full Text] [Related]
34. Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease. Tsujikawa T; Andoh A; Inatomi O; Bamba S; Nakahara T; Sasaki M; Saito H; Fujiyama Y Intern Med; 2009; 48(12):933-7. PubMed ID: 19525577 [TBL] [Abstract][Full Text] [Related]
35. The effects of eggshell calcium (Biomin H Omelka R; Martiniakova M; Svik K; Slovak L; Payer J; Oppenbergerova I; Kovacova V; Babikova M; Soltesova-Prnova M J Anim Physiol Anim Nutr (Berl); 2021 Mar; 105(2):336-344. PubMed ID: 33012134 [TBL] [Abstract][Full Text] [Related]
36. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
37. Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease. Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Suzuki S; Miura S Nephrol Dial Transplant; 2007 Jun; 22(6):1593-600. PubMed ID: 17041001 [TBL] [Abstract][Full Text] [Related]
38. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Bak M; Serdaroglu E; Guclu R Pediatr Nephrol; 2006 Mar; 21(3):350-4. PubMed ID: 16382319 [TBL] [Abstract][Full Text] [Related]
39. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. Ringe JD; Faber H; Fahramand P; Schacht E J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849 [TBL] [Abstract][Full Text] [Related]
40. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]